National Natural Science Foundation of China (grant
81872101, Z. Wang) and the Natural Science Foundation of Hebei Province
(grant H2020206572, Z.Wang).
第一作者机构:[1]Department of Immuno-Oncology, The Fourth Hospital of Hebei Medical University, Shijiazhuang, Hebei, China
通讯作者:
通讯机构:[1]Department of Immuno-Oncology, The Fourth Hospital of Hebei Medical University, Shijiazhuang, Hebei, China[*1]Department of Immuno-Oncology, The Fourth Hospital of Hebei Medical University, No. 12, Jiankang Rd., Chang’an District, Shijiazhuang, Hebei 050011, China.
推荐引用方式(GB/T 7714):
Zhang Yuehua,Li Wen,Guo Shenghu,et al.FBXO22 Mediates the NGF/TRKA Signaling Pathway in Bone Metastases in Prostate Cancer[J].AMERICAN JOURNAL OF PATHOLOGY.2023,193(9):1248-1266.doi:10.1016/j.ajpath.2023.05.012.
APA:
Zhang Yuehua,Li Wen,Guo Shenghu,Wu Zheng,Zhang Lei...&Wang Zhiyu.(2023).FBXO22 Mediates the NGF/TRKA Signaling Pathway in Bone Metastases in Prostate Cancer.AMERICAN JOURNAL OF PATHOLOGY,193,(9)
MLA:
Zhang Yuehua,et al."FBXO22 Mediates the NGF/TRKA Signaling Pathway in Bone Metastases in Prostate Cancer".AMERICAN JOURNAL OF PATHOLOGY 193..9(2023):1248-1266